|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
07630 IMPACT THERAP-B
Nominal 
12.900 +1.280 (+11.015%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (95,880) | (81,311) |
| Net Cash from / (used in) Investing Activities | -- | 112,816 | (109,854) |
| Net Cash from / (used in) Financing Activities | -- | 13,469 | 148,332 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 30,405 | (42,833) |
| Cash & Cash Equivalents at beginning of period | -- | 230,122 | 271,318 |
| Effect of Foreign Exchange Rate Changes | -- | (1,993) | 1,637 |
| Others | -- | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 258,534 | 230,122 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -90,810 |
| %Change | -29.457% |
| EPS / (LPS) | RMB -0.370 |
| NBV Per Share (¥) | RMB 2.746 |